Horizon Therapeutics Public Ltd Co Share-based Payment Arrangement, Expense in USD from 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Horizon Therapeutics Public Ltd Co quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to Q1 2023.
  • Horizon Therapeutics Public Ltd Co Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $58.1M, a 22.9% increase year-over-year.
  • Horizon Therapeutics Public Ltd Co Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $193M, a 5.99% decline year-over-year.
  • Horizon Therapeutics Public Ltd Co annual Share-based Payment Arrangement, Expense for 2022 was $182M, a 16.9% decline from 2021.
  • Horizon Therapeutics Public Ltd Co annual Share-based Payment Arrangement, Expense for 2021 was $219M, a 49.4% increase from 2020.
  • Horizon Therapeutics Public Ltd Co annual Share-based Payment Arrangement, Expense for 2020 was $147M, a 60.7% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Horizon Therapeutics Public Ltd Co Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $193M $58.1M +$10.8M +22.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $182M $44.6M -$4.11M -8.44% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 $186M $45.1M -$9.74M -17.8% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $196M $45.1M -$9.28M -17% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $205M $47.3M -$13.9M -22.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $219M $48.7M +$15.9M +48.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $203M $54.8M +$24.4M +80.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $179M $54.4M +$27.4M +101% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $151M $61.2M +$4.75M +8.41% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $147M $32.8M +$8.64M +35.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $138M $30.4M +$12.2M +67.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $126M $27.1M +$5.69M +26.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $120M $56.4M +$28.9M +105% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $91.2M $24.1M -$3.73M -13.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $94.9M $18.2M -$10.3M -36.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $105M $21.4M -$9.35M -30.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $115M $27.5M -$285K -1.02% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $115M $27.9M -$5.74M -17.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $121M $28.4M -$3.27M -10.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $124M $30.7M +$2.95M +10.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $121M $27.8M -$636K -2.23% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $122M $33.6M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $31.7M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $27.8M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $28.5M +$857K +3.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q1 2016 $27.6M +$20.9M +314% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q1 2015 $6.67M +$4.75M +246% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q1 2014 $1.93M +$848K +78.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q1 2013 $1.08M -$680K -38.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q1 2012 $1.76M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10

Horizon Therapeutics Public Ltd Co Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $182M -$37M -16.9% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-01
2021 $219M +$72.5M +49.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 $147M +$55.4M +60.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $91.2M -$23.6M -20.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $115M -$6.69M -5.51% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $122M +$7.41M +6.49% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $114M +$28.4M +33.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $85.8M +$72.6M +550% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-28
2014 $13.2M +$8.18M +163% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 $5.01M +$353K +7.57% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $4.66M +$2.13M +84.2% Jan 1, 2012 Dec 31, 2012 10-K/A 2015-03-02
2011 $2.53M -$44K -1.71% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-13
2010 $2.57M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.